跳至主要内容
临床试验/NL-OMON39343
NL-OMON39343尚未招募4 期

Magnetic Resonance Imaging to diagnose endometriosis using Ablavar ® as contrast agent - a feasibility study - Ablavar ® in endometriosis diagnosis

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Older that 18 years;
  • Suspect of peritoneal endometriosis, palpable nodule at physical examination;
  • Patient planned for MRI and laparoscopic treatment of the disease;
  • Pre menopausal;
  • Using contraception during the time of the study;
  • Willing and able to undergo all study procedures;
  • written informed consent.

排除标准

  • Pregnancy / breast feeding;
  • Post menopausal status or under GnRH analogue treatment;
  • Patients presenting with a contraindication to MRI such as pacemaker, aneurysm clip, severe claustrophobia or ferromagnetic implants;
  • Impaired kidney function (estimated Glomerular Filtration Rate, eGFR < 60) or acute kidney injury;
  • History of severe allergic reaction or allergic reaction to MR contrast media;
  • Allergy (hypersensitivity) to any of the ingredients of Ablavar ®;
  • Being unable to give informed consent in person.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验